LONDON, UK / ACCESS Newswire / July 3, 2025 / UTILITY therapeutics Ltd. (UTILITY), a biotechnology company focused on the development of PIVYA (pivmecillinam 185 mg tablets), a penicillin class ...
BEDMINSTER, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics, LLC announces the acquisition of NUVESSA® (metronidazole vaginal gel 1.3%), an FDA-approved prescription medication indicated ...
Alembic Pharmaceuticals on Thursday said its US arm has acquired Utility Therapeutics Ltd in a $12 million (over Rs 100 crore) deal to strengthen its presence in the American market. The acquisition ...
Nlembic Pharmaceuticals I nc., the US subsidiary of Alembic Pharmaceuticals, has acquired Utility Therapeutics Ltd in a $12 million deal to strengthen its presence in the US market. Alembic will begin ...
Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infections PIVYA expected to be available in the U.S. in the 4th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results